Chemical Structure (Image 01)
Oseltamivir Phosphate Capsule
Product Images NDC 70436-225
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 70436-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton Label (Image 02)
Oseltamivir Phosphate Capsules, USP 75mg is a medication available in a pack of 10 capsules. Each capsule contains oseltamivir phosphate equivalent to 75 mg oseltamivir. This medication is manufactured by Zhejiang Poly Pham. Co., Ltd. in China and distributed by Slate Run Pharmaceuticals in Columbus, Ohio. The usual dosage and other important prescribing information can be found in the accompanying insert. The capsules should be stored at 25°C (77°F) with excursions permitted to 15° to 30°C (59° to 86°F).*
75 mg 10 Capsule Carton (Image 03)
This is a description for Oseltamivir Phosphate Capsules, USP. Each capsule contains 75mg of oseltamivir phosphate, which is equivalent to 75mg of oseltamivir (free base). There are 10 capsules in the package. The recommended dosage and important prescribing information can be found in the accompanying insert. The capsules should be stored at a temperature of 25°C (77°F), with excursions permitted between 15° to 30°C (59° to 86°F). The medication is manufactured by Hainan Poly Pham Co., Ltd. and Zhejiang Poly Pham Co., Ltd. in China. It is distributed by Slate Run Pharmaceuticals, LLC in Columbus, Ohio. The expiration date for this batch is December 2023.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
